Shringarpure Kalpita S, Isaakidis Petros, Sagili Karuna D, Baxi R K, Das Mrinalini, Daftary Amrita
Department of Preventive Social Medicine, Medical College, Baroda, India.
Operational Research Unit, Médecins Sans Frontières, Mumbai, India.
PLoS One. 2016 Mar 9;11(3):e0150849. doi: 10.1371/journal.pone.0150849. eCollection 2016.
One-fifth of the patients on multidrug-resistant tuberculosis treatment at the Drug-Resistant-TB (DR-TB) Site in Gujarat are lost-to-follow-up(LFU).
To understand patients' and providers' perspectives on reasons for LFU and their suggestions to improve retention-in-care.
Qualitative study conducted between December 2013-March 2014, including in-depth interviews with LFU patients and DOT-providers, and a focus group discussion with DR-TB site supervisors. A thematic-network analysis approach was utilised.
Three sub-themes emerged: (i) Struggle with prolonged treatment; (ii) Strive against stigma and toward support; (iii) Divergent perceptions and practices. Daily injections, pill burden, DOT, migratory work, social problems, prior TB treatment, and adverse drugs effects were reported as major barriers to treatment adherence and retention-in-care by patients and providers. Some providers felt that despite their best efforts, LFU patients remain. Patient movements between private practitioners and traditional healers further influenced LFU.
The study points to a need for repeated patient counselling and education, improved co-ordination between various tiers of providers engaged in DR-TB care, collaboration between the public, private and traditional practitioners, and promotion of social and economic support to help patients adhere to MDR-TB treatment and avoid LFU.
在古吉拉特邦耐药结核病治疗点接受耐多药结核病治疗的患者中有五分之一失访。
了解患者和医护人员对失访原因的看法以及他们对改善治疗依从性的建议。
2013年12月至2014年3月进行的定性研究,包括对失访患者和直接观察治疗提供者的深入访谈,以及与耐药结核病治疗点主管的焦点小组讨论。采用主题网络分析方法。
出现了三个子主题:(i)与长期治疗作斗争;(ii)对抗耻辱感并寻求支持;(iii)不同的观念和做法。患者和医护人员报告称,每日注射、服药负担、直接观察治疗、流动工作、社会问题、既往结核病治疗以及药物不良反应是治疗依从性和治疗持续率的主要障碍。一些医护人员认为,尽管他们尽了最大努力,但失访患者仍然存在。患者在私人执业医生和传统治疗师之间的流动进一步影响了失访情况。
该研究表明需要对患者进行反复咨询和教育,改善参与耐多药结核病治疗的各层级医护人员之间的协调,促进公共、私人和传统从业者之间的合作,并提供社会和经济支持,以帮助患者坚持耐多药结核病治疗并避免失访。